List of insiders holdings for Syndax Pharmaceuticals Inc:
- Shares directly owned by the insider.
- Shares indirectly owned by the insider.
- Total shares owned by the insider (sum of shares directly and indirectly owned).
- Total market value if available.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| # | Insider Holder Name | Report Date Time |
Shares Owned Directly Indirectly |
Total Shares Owned |
Filing |
| 1 | Domain Partners VI L.P. BLAIR JAMES C DOVEY BRIAN H TREU JESSE I VITULLO NICOLE 10% Owner |
2016-03-08 11:47:21 | 1,743,854 0 |
1,743,854 | Form 4 |
| 2 | BVF PARTNERS L P BIOTECHNOLOGY VALUE FUND L P BIOTECHNOLOGY VALUE FUND II LP Biotechnology Value Trading Fund OS LP BVF Partners OS Ltd. BVF INC LAMPERT MARK N 10% Owner |
2023-02-14 11:53:10 | 1,451,197 0 |
1,451,197 | Form 13G |
| 3 | Domain Partners VIII L.P. BLAIR JAMES C DOVEY BRIAN H TREU JESSE I VITULLO NICOLE Halak Brian K 10% Owner |
2021-01-20 19:57:09 | 1,162,554 0 |
1,162,554 | Form 13G |
| 4 | ROYSTON IVOR Director |
2017-03-22 13:37:24 | 0 625,545 |
625,545 | Form 4 |
| 5 | Metzger Michael A Chief Executive Officer |
2025-03-17 06:01:11 | 306,195 0 |
306,195 | Form 4 |
| 6 | Sabus Steve M Chief Commercial Officer |
2022-12-05 16:41:39 | 220,000 0 |
220,000 | Form 4 |
| 7 | Podlesak Dennis Director |
2025-02-07 16:41:27 | 191,763 0 |
191,763 | Form 4 |
| 8 | Shaw Allan Chief Financial Officer |
2016-03-02 18:06:46 | 137,600 0 |
137,600 | Form 3 |
| 9 | Madigan Catherine Chief Medical Officer |
2023-02-03 17:01:12 | 110,000 0 |
110,000 | Form 4 |
| 10 | Karydas Daphne Chief Financial Officer |
2021-02-05 16:22:19 | 95,000 0 |
95,000 | Form 4 |
| 11 | Goldan Keith A. Chief Financial Officer |
2025-02-12 17:16:46 | 90,746 0 |
90,746 | Form 4 |
| 12 | Meury William Director |
2025-02-07 16:38:33 | 90,000 0 |
90,000 | Form 4 |
| 13 | Katkin Keith Director |
2025-02-07 16:37:19 | 90,000 0 |
90,000 | Form 4 |
| 14 | Jarrett Jennifer Director |
2025-02-07 16:35:56 | 90,000 0 |
90,000 | Form 4 |
| 15 | Legault Pierre Director |
2025-02-07 16:32:17 | 90,000 0 |
90,000 | Form 4 |
| 16 | Gallagher Neil President, Head of R&D |
2025-02-12 17:13:24 | 85,095 0 |
85,095 | Form 4 |
| 17 | Huber Martin H. Jr. Director |
2025-02-07 16:34:03 | 74,000 0 |
74,000 | Form 4 |
| 18 | Shea Richard P Chief Financial Officer |
2020-02-14 16:37:17 | 53,227 0 |
53,227 | Form 4 |
| 19 | Meyers Michael L. SVP, Chief Medical Officer |
2022-02-03 17:31:53 | 42,344 0 |
42,344 | Form 4 |
| 20 | Morrison Briggs Director |
2024-02-09 16:04:08 | 34,836 0 |
34,836 | Form 4 |
| 21 | Egros Fabrice Director |
2022-02-03 17:29:44 | 32,000 0 |
32,000 | Form 4 |
| 22 | Rizo Aleksandra Director |
2025-02-07 16:39:46 | 25,000 0 |
25,000 | Form 4 |
| 23 | Nolte Alexander Chief Accounting Officer |
2023-02-03 16:58:24 | 17,000 0 |
17,000 | Form 4 |
| 24 | Chen Henry Director |
2018-05-25 09:00:25 | 14,000 0 |
14,000 | Form 4 |
| 25 | EVNIN LUKE Director 10% Owner |
2018-05-25 09:00:11 | 14,000 0 |
14,000 | Form 4 |
| 26 | DP VI Associates L.P. BLAIR JAMES C DOVEY BRIAN H TREU JESSE I VITULLO NICOLE Director 10% Owner |
2016-03-08 11:52:26 | 13,925 0 |
13,925 | Form 4 |
| 27 | DOMAIN ASSOCIATES BLAIR JAMES C DOVEY BRIAN H TREU JESSE I VITULLO NICOLE Halak Brian K Kamdar Kim P. Shah Nimesh 10% Owner |
2016-03-02 18:37:27 | 13,564 0 |
13,564 | Form 3 |
| 28 | Kamdar Kim P. Director 10% Owner |
2016-11-02 16:44:50 | 8,000 0 |
8,000 | Form 4 |
| 29 | DP VIII Associates L.P. BLAIR JAMES C DOVEY BRIAN H TREU JESSE I VITULLO NICOLE Halak Brian K 10% Owner |
2016-03-08 11:41:42 | 5,641 0 |
5,641 | Form 4 |
| 30 | Sledge George W. Jr. Director |
2017-05-19 11:27:01 | 5,000 0 |
5,000 | Form 4 |
| 31 | Ordentlich Peter Chief Scientific Officer |
2023-02-17 18:09:58 | 0 0 |
0 | Form 4 |
| 32 | MPM BioVentures IV QP LP Scopa James Paul Foley Todd GADICKE ANSBERT KAILIAN VAUGHN M MPM Asset Management Investors BV4 LLC MPM BioVentures IV GmbH & Co. Beteiligungs KG MPM BioVentures IV GP LLC MPM BioVentures IV LLC MPM BioVentures IV Strategic Fund L.P. 10% Owner |
2021-02-12 16:06:57 | 0 0 |
0 | Form 13G |